Branford, CT, United States of America

Erik Gunnar Jagdmann

This inventor holds 1 USPTO granted patent. Top assignee: Yale University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Gunnar Jagdmann. Retrieved from https://idiyas.com/inventor/erik-gunnar-jagdmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Erik Gunnar Jagdmann

Introduction

Erik Gunnar Jagdmann is an accomplished inventor based in Branford, CT (US). He has made significant contributions to the field of molecular biology, particularly in the area of RNA research. His innovative work focuses on developing methods to inhibit group II intron splicing, which has implications for treating various diseases.

Latest Patents

Erik holds a patent for "Compositions and methods for inhibiting group II intron RNA." This invention provides compositions and methods aimed at inhibiting group II intron splicing to treat or prevent diseases associated with organisms harboring active group II introns. The patent also outlines methods for inhibiting, preventing, or reducing the growth of such organisms.

Career Highlights

Erik is affiliated with Yale University, where he conducts research and collaborates with other scientists. His work has garnered attention for its potential applications in medical science and biotechnology. With 1 patent to his name, he continues to push the boundaries of scientific understanding.

Collaborations

Some of Erik's notable coworkers include Anna Marie Pyle and Olga Fedorova. Their collaborative efforts contribute to the advancement of research in RNA biology and related fields.

Conclusion

Erik Gunnar Jagdmann's innovative contributions to the field of RNA research highlight the importance of scientific inquiry in addressing complex biological challenges. His work exemplifies the impact of dedicated inventors in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…